REA Group (ASX: REA) Records Resilient Results In H1 FY 2024
REA Group reports another solid set of results for H1 FY 2024 but what will unlock future growth in REA’s earnings over the long haul?
Ethical Equities Investing
Cettire (ASX: CTT) Revenue Soars In 1H FY 2024
Cettire (ASX: CTT) records extraordinary growth in revenue and net profit for 1H FY 2024 but is there more to it than just top-line growth?
Is Nick Scali (ASX: NCK) Still A Plush Investment After A Fall In Net Profits for 1H FY 2024?
Nick Scali (ASX: NCK) has an incredible track record of creating value shareholders. What is behind the success and can it continue?
Is The SDI Limited (ASX: SDI) Share Price Too Low?
SDI Limited (ASX: SDI) trades on a trailing yield of over 4.5%, fully franked, and a trailing P/E ratio of around 12.5x.
Playside (ASX: PLY) Breaks Records In Q2 FY 2024
Playside (ASX: PLY) punched in a stellar set of results for Q2 FY 2024 and the Playside share price jumped double digits. Here’s my take.
This Unloved Nano-cap Is Profitable, Cash Flow Positive and Growing
Nano-caps are not for everyone, due to minimal liquidity. But sometimes they seem undervalued.
Mader (ASX: MAD) Records Solid Q2 FY 2024 Results
The Mader (ASX: MAD) quarterly update shows strong profit growth and reduced debt.
Why Keypath Education (ASX: KED) Looks Interesting
Keypath Education (ASX: KED) has been a big disappointment for shareholders but Keypath share price already reflects this.
RocketDNA (ASX: RKT) Shows Low Revenue Growth, Despite Cash Burn
Lacklustre revenue growth and ongoing cash burn meant the RocketDNA (ASX: RKT) share price had a failure to launch.
Could The Electric Vehicle Transition Benefit Car Group Ltd (ASX: CAR)?
Car Group (ASX: CAR) stock may not be cheap at the moment, but it is a good quality company with plenty of room to grow.
Dropsuite (ASX: DSE) Q4 FY 2023 Update
The Q4 FY 2023 Dropsuite (ASX: DSE) Results were quite weak but that is no surprise after a bumper quarter in Q3.
Why Compumedics (ASX: CMP) May Be At An Inflection Point
Sequential positive announcements have been driven the Compumedics share price higher.
2 Tempting Micro-caps That I Think Are Undervalued
One offers steady growth at a discount, while the other offers hope of a turnaround — and heavy insider buying.
CY 2023 Investing Performance Review
The six months to June 30, 2023 were painful while the six months to December 31, 2023 were a joy.
An Introduction To Genex Power (ASX: GNX)
Genex Power (ASX: GNX) is doing good in the world; but is it a good stock?
An Introduction To Acusensus (ASX: ACE)
Acusensus (ASX: ACE) uses advanced technology to surveil and photograph drivers while they breaching road rules.
An Introduction To RAS Technology Holdings (ASX: RTH)
RAS Technology Holdings is showing stellar revenue growth; but what are the risks
Observations From The 2023 Supply Network (ASX: SNL) AGM
Raymond Jang brings you his in-person impressions from attending the 2023 Supply Network AGM.
Are Xero (ASX: XRO) Shares Good Value After The H1 FY 2024 Results?
The share price of Xero (ASX: XRO) fell sharply after the H1 FY 2024 results; but does that make it cheap?
Is The Vysarn (ASX: VYS) Share Price Still Reasonable, After More Than Doubling?
Vysarn’s AGM update gives us insight into to why the share price has risen, and where the company is headed.